Biopharmaceutical Third Party Logistics Market Size US$ 150.2 BN 2030

The global biopharmaceutical third party logistics market size is expected to surpass around US$ 150.2 billion by 2030 and expanding growth at a CAGR of 6.6% from 2021 to 2030.

 The rising trend of outsourcing logistics, the focus of pharmaceutical players on their distribution network owing to its strong sales numbers, and the rise in the number of biosimilar launches are some of the key factors driving the market.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38820

hese advanced vehicles are designed to automate and provide temperature control systems during transportation that help in reducing complexities, human error, and damage to products in transit. Thus, these monitoring solutions allow visibility that can converse breaches through automatic alerts by providing information to execute contingency plans.

By Supply Chain Analysis

the non-cold chain logistics segment dominated the market for biopharmaceutical third-party logistics (3PL) and contributed to the largest revenue share of 80.8%. This is owing to an increase in pharmaceutical sales through distributors. 3PL services provide greater scalability, higher visibility, reduce overall operating costs, and help develop a stronger logistics network with higher returns and lower risks. 

The cold chain is projected to be the fastest-growing supply chain segment with a CAGR of 9.6% in the market for biopharmaceutical third-party logistics (3PL) over the forecast period. This is majorly owing to the rising demand for a new class of drugs, called biologics that have shown tremendous growth over the past few years.

Report Coverage

By Service Type Analysis

the warehousing and storage segment dominated the market for biopharmaceutical third-party logistics (3PL) and held the largest revenue share of 43.6%. This is attributed to a large demand for 3PL services from the pharmaceutical and healthcare industry. 

The other segment is projected to expand at a lucrative CAGR of 6.4% in the market for biopharmaceutical third-party logistics (3PL) over the forecast period. Packaging, custom and duty management, procurement services, and a few other values added services are included in this segment.

By Regional Analysis

North America dominated the biopharmaceutical third-party logistics (3PL) market and accounted for the largest revenue share of 41.5% in 2020. This is majorly attributed to the dominance of the region in the biologics and pharmaceutical drugs market and an increase in exports and imports for biopharmaceuticals. 

In Asia Pacific, the market for biopharmaceutical third-party logistics (3PL) witnessed the second largest revenue of USD 15.4 billion in 2020 and is also expected to witness the fastest CAGR of 7.2% over the forecast period. 

Key Players

• FedEx.
• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• AmerisourceBergen Corporation
• DB Schenker
• KUEHNE + NAGEL
• Kerry Logistics Network Limited
• Agility 

Market Segmentation

• By Supply Chain
  • Cold Chain
  • Non-cold Chain
• By Service Type
  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Others
• Regional 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38820

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333